BCAL Diagnostics (ASX: BDX) Share Price

BDX

$0.07▲+2.94%

$25.8MRank #1220 on ASXHealthcareMedical - Diagnostics & Research

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$25.8M

Volume

184K

P/E Ratio

-2.45

EPS

-$0.0107

Dividend Yield

0.00%

52-Week High

$0.155

52-Week Low

$0.052

Beta

0.813

BCAL Diagnostics (ASX: BDX) is an Australian-listed company in the Healthcare sector with a market capitalisation of $25.8M and the 1220th-largest security on the ASX by market capitalisation. The BDX share price is $0.07, up 2.94% today and up 1.45% over the past 12 months. Shares have traded between $0.052 and $0.155 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), BCAL Diagnostics reported revenue of $42,618 and a net loss of $3.9M.

Charts

$0.07

24H Range

$0.068

$0.073

52-Week Range

$0.052

$0.155

About BCAL Diagnostics Limited

BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.

IPO Date

21 July 2021

CEO

Shane Ryan

Website

bcaldiagnostics.com

Key Financial Data

Revenue (Quarterly)	$42,618
Net Income (Quarterly)	$-3.9M
Total Assets	$7.2M
Total Debt	$3.8M
Free Cash Flow	$-2.9M
Return on Equity	-156.83%
Profit Margin	-9191.92%
Operating Margin	-11776.57%

BDX Frequently Asked Questions

What is the BCAL Diagnostics (ASX: BDX) share price?

The BDX share price is $0.07, up 2.94% for the day, based on the latest available ASX market data.

What is BCAL Diagnostics's market capitalisation?

BCAL Diagnostics has a market capitalisation of $25.8M, making it the 1220th-largest security listed on the ASX.

Does BCAL Diagnostics pay a dividend?

BDX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is BCAL Diagnostics profitable?

In its most recent reported period (ending 31 Dec 2025), BDX reported revenue of $42,618 and a net loss of $3.9M.

How many BDX shares are on issue?

BCAL Diagnostics has approximately 368,683,000 shares on issue, based on its market capitalisation of $25.8M and current share price.

What sector is BCAL Diagnostics in?

BCAL Diagnostics is classified in the Healthcare sector, within the Medical - Diagnostics & Research industry on the ASX.

When did BCAL Diagnostics list on the ASX?

BCAL Diagnostics listed on the Australian Securities Exchange on 21 July 2021.

Latest News

Health Check: Cancer assay developer BCAL finds quickest, breast route to the US

Stockhead28 May 2026

Health Check: Cancer assay developer BCAL finds quickest, breast route to the US Stockhead

BCAL expands early cancer detection access to 97% of Australian GPs

Proactive Investors19 May 2026

BCAL expands early cancer detection access to 97% of Australian GPs Proactive Investors

When Will BCAL Diagnostics Limited (ASX:BDX) Turn A Profit?

Yahoo Finance9 Feb 2025

When Will BCAL Diagnostics Limited (ASX:BDX) Turn A Profit? Yahoo Finance

BCAL Diagnostics Limited (ASX: BDX) - Announcements

intelligentinvestor.com.au28 Dec 2021

BCAL Diagnostics Limited (ASX: BDX) - Announcements intelligentinvestor.com.au

BCAL Diagnostics Launches BREASTEST plus - Generating First Revenues

Investing News Network23 Mar 2025

BCAL Diagnostics Launches BREASTEST plus - Generating First Revenues Investing News Network

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
RHYRhythm Biosciences Limited	$38.9M	$0.11	-4.75	0.00%	–+0.00%
IIQINOVIQ Ltd	$36.8M	$0.315	-3.02	0.00%	–+0.00%
EYENova Eye Medical Limited	$34.2M	$0.12	-2.79	0.00%	▲+6.67%
HMDHeraMED Limited	$30.1M	$0.038	-5.14	0.00%	▲+2.70%
EMDEmyria Limited	$24.1M	$0.042	-4.21	0.00%	▲+2.44%
NOXNoxopharm Limited	$23.7M	$0.077	-3.69	0.00%	▼-3.75%
MAPMicroba Life Sciences Limited	$23.6M	$0.046	-1.06	0.00%	▼-26.98%
AGNArgenica Therapeutics Limited	$16.7M	$0.13	-2.48	0.00%	▲+4.00%

ETFs That Hold BDX

BDX is held by 9 ASX-listed funds tracked on this site. The largest allocation is in iShares Global Healthcare ETF (ASX: IXJ) at 0.64% of its portfolio.

Fund	Portfolio Weight	Fund Size
IXJiShares Global Healthcare ETF	0.64%	$1.33B
VVLUVanguard Global Value Equity Active ETF	0.46%	$1.20B
WVOLiShares MSCI World ex Australia Minimum Volatility ETF	0.26%	$78.7M
IVViShares S&P 500 ETF	0.09%	$13.96B
VTSVanguard U.S. Total Market Shares Index ETF	0.09%	$9.53B
IHVViShares S&P 500 (AUD Hedged) ETF	0.09%	$4.11B
VESGVanguard Ethically Conscious International Shares Index ETF	0.09%	$1.49B
VGSVanguard MSCI Index International Shares ETF	0.07%	$13.16B
VGADVanguard MSCI Index International Shares (Hedged) ETF	0.07%	$7.39B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.07	$0.073	$0.068	$0.07	184K	▲+2.94%
11 June 2026	$0.068	$0.068	$0.068	$0.068	16K	▼-2.86%
10 June 2026	$0.068	$0.071	$0.065	$0.07	538K	–+0.00%
9 June 2026	$0.068	$0.071	$0.065	$0.07	538K	▼-5.41%
8 June 2026	$0.075	$0.075	$0.074	$0.074	4.1K	–+0.00%
5 June 2026	$0.075	$0.075	$0.074	$0.074	4.1K	–+0.00%
4 June 2026	$0.075	$0.075	$0.074	$0.074	4.1K	▼-1.33%
3 June 2026	$0.079	$0.079	$0.075	$0.075	134K	▼-3.85%
2 June 2026	$0.078	$0.078	$0.078	$0.078	21K	–+0.00%
1 June 2026	$0.079	$0.079	$0.078	$0.078	86K	–+0.00%
29 May 2026	$0.079	$0.079	$0.078	$0.078	86K	▲+2.63%
28 May 2026	$0.079	$0.079	$0.075	$0.076	120K	▼-5.00%
27 May 2026	$0.08	$0.08	$0.08	$0.08	1.4K	–+0.00%
26 May 2026	$0.08	$0.08	$0.08	$0.08	1.4K	▲+5.26%
25 May 2026	$0.076	$0.076	$0.075	$0.076	47K	▲+2.70%
22 May 2026	$0.076	$0.077	$0.074	$0.074	283K	▼-1.33%
21 May 2026	$0.077	$0.077	$0.075	$0.075	61K	▼-1.32%
20 May 2026	$0.08	$0.08	$0.076	$0.076	29K	▼-2.56%
19 May 2026	$0.081	$0.096	$0.078	$0.078	607K	▲+1.30%
18 May 2026	$0.075	$0.078	$0.075	$0.077	51K	▼-7.23%
15 May 2026	$0.083	$0.083	$0.083	$0.083	64K	–+0.00%
14 May 2026	$0.083	$0.083	$0.083	$0.083	64K	–+0.00%
13 May 2026	$0.083	$0.083	$0.083	$0.083	64K	▲+2.47%
12 May 2026	$0.081	$0.081	$0.081	$0.081	29K	▼-2.41%
11 May 2026	$0.076	$0.083	$0.075	$0.083	265K	▲+12.16%
8 May 2026	$0.074	$0.074	$0.074	$0.074	54	▲+4.23%
7 May 2026	$0.076	$0.076	$0.071	$0.071	131K	▼-5.33%
6 May 2026	$0.077	$0.078	$0.073	$0.075	443K	▼-3.85%
5 May 2026	$0.078	$0.078	$0.078	$0.078	2K	▲+4.00%
4 May 2026	$0.075	$0.075	$0.075	$0.075	36K	▼-9.64%

About BCAL Diagnostics Limited

IPO Date

21 July 2021

CEO

Shane Ryan

Website

bcaldiagnostics.com

BDX Frequently Asked Questions

What is the BCAL Diagnostics (ASX: BDX) share price?

The BDX share price is $0.07, up 2.94% for the day, based on the latest available ASX market data.

What is BCAL Diagnostics's market capitalisation?

BCAL Diagnostics has a market capitalisation of $25.8M, making it the 1220th-largest security listed on the ASX.

Does BCAL Diagnostics pay a dividend?

BDX does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is BCAL Diagnostics profitable?

In its most recent reported period (ending 31 Dec 2025), BDX reported revenue of $42,618 and a net loss of $3.9M.

How many BDX shares are on issue?

BCAL Diagnostics has approximately 368,683,000 shares on issue, based on its market capitalisation of $25.8M and current share price.

What sector is BCAL Diagnostics in?

BCAL Diagnostics is classified in the Healthcare sector, within the Medical - Diagnostics & Research industry on the ASX.

When did BCAL Diagnostics list on the ASX?

BCAL Diagnostics listed on the Australian Securities Exchange on 21 July 2021.

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
RHYRhythm Biosciences Limited	$38.9M	$0.11	-4.75	0.00%	–+0.00%
IIQINOVIQ Ltd	$36.8M	$0.315	-3.02	0.00%	–+0.00%
EYENova Eye Medical Limited	$34.2M	$0.12	-2.79	0.00%	▲+6.67%
HMDHeraMED Limited	$30.1M	$0.038	-5.14	0.00%	▲+2.70%
EMDEmyria Limited	$24.1M	$0.042	-4.21	0.00%	▲+2.44%
NOXNoxopharm Limited	$23.7M	$0.077	-3.69	0.00%	▼-3.75%
MAPMicroba Life Sciences Limited	$23.6M	$0.046	-1.06	0.00%	▼-26.98%
AGNArgenica Therapeutics Limited	$16.7M	$0.13	-2.48	0.00%	▲+4.00%

Fund

Portfolio Weight

Fund Size

IXJiShares Global Healthcare ETF

0.64%

$1.33B

VVLUVanguard Global Value Equity Active ETF

0.46%

$1.20B

WVOLiShares MSCI World ex Australia Minimum Volatility ETF

0.26%

$78.7M

IVViShares S&P 500 ETF

0.09%

$13.96B

VTSVanguard U.S. Total Market Shares Index ETF

0.09%

$9.53B

IHVViShares S&P 500 (AUD Hedged) ETF

0.09%

$4.11B

VESGVanguard Ethically Conscious International Shares Index ETF

0.09%

$1.49B

VGSVanguard MSCI Index International Shares ETF

0.07%

$13.16B

VGADVanguard MSCI Index International Shares (Hedged) ETF

0.07%

$7.39B

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.07	$0.073	$0.068	$0.07	184K	▲+2.94%
11 June 2026	$0.068	$0.068	$0.068	$0.068	16K	▼-2.86%
10 June 2026	$0.068	$0.071	$0.065	$0.07	538K	–+0.00%
9 June 2026	$0.068	$0.071	$0.065	$0.07	538K	▼-5.41%
8 June 2026	$0.075	$0.075	$0.074	$0.074	4.1K	–+0.00%
5 June 2026	$0.075	$0.075	$0.074	$0.074	4.1K	–+0.00%
4 June 2026	$0.075	$0.075	$0.074	$0.074	4.1K	▼-1.33%
3 June 2026	$0.079	$0.079	$0.075	$0.075	134K	▼-3.85%
2 June 2026	$0.078	$0.078	$0.078	$0.078	21K	–+0.00%
1 June 2026	$0.079	$0.079	$0.078	$0.078	86K	–+0.00%
29 May 2026	$0.079	$0.079	$0.078	$0.078	86K	▲+2.63%
28 May 2026	$0.079	$0.079	$0.075	$0.076	120K	▼-5.00%
27 May 2026	$0.08	$0.08	$0.08	$0.08	1.4K	–+0.00%
26 May 2026	$0.08	$0.08	$0.08	$0.08	1.4K	▲+5.26%
25 May 2026	$0.076	$0.076	$0.075	$0.076	47K	▲+2.70%
22 May 2026	$0.076	$0.077	$0.074	$0.074	283K	▼-1.33%
21 May 2026	$0.077	$0.077	$0.075	$0.075	61K	▼-1.32%
20 May 2026	$0.08	$0.08	$0.076	$0.076	29K	▼-2.56%
19 May 2026	$0.081	$0.096	$0.078	$0.078	607K	▲+1.30%
18 May 2026	$0.075	$0.078	$0.075	$0.077	51K	▼-7.23%
15 May 2026	$0.083	$0.083	$0.083	$0.083	64K	–+0.00%
14 May 2026	$0.083	$0.083	$0.083	$0.083	64K	–+0.00%
13 May 2026	$0.083	$0.083	$0.083	$0.083	64K	▲+2.47%
12 May 2026	$0.081	$0.081	$0.081	$0.081	29K	▼-2.41%
11 May 2026	$0.076	$0.083	$0.075	$0.083	265K	▲+12.16%
8 May 2026	$0.074	$0.074	$0.074	$0.074	54	▲+4.23%
7 May 2026	$0.076	$0.076	$0.071	$0.071	131K	▼-5.33%
6 May 2026	$0.077	$0.078	$0.073	$0.075	443K	▼-3.85%
5 May 2026	$0.078	$0.078	$0.078	$0.078	2K	▲+4.00%
4 May 2026	$0.075	$0.075	$0.075	$0.075	36K	▼-9.64%